Research report: Case Report: Hyperactive delirium with psychotic symptoms associated with severe hypothyroidism during pembrolizumab therapy. Complete remission after levothyroxine and no recurrence after pembrolizumab rechallenge
A 78-year-old woman developed hyperactive delirium with hallucinations and persecutory delusions during pembrolizumab therapy, and her symptoms fully resolved after ...
